View Post

New insight into why malaria drugs work against some cancers could boost drug development

In Clinical Trials by Barbara Jacoby

By: Arlene Weintraub From: fiercebiotech.com There are currently about 20 clinical trials underway evaluating a class of malaria drugs known as chloroquines in several tumor types, including breast cancer, lung cancer and multiple solid tumors, according to ClinicalTrials.gov. Anti-malarial drugs, in fact, have long been of interest in the oncology community because of their ability to shrink some cancers. But …

View Post

New virus could help destroy cancer

In In The News by Barbara Jacoby

By: Chiara Townley From: medicalnewstoday.com A new study examines the behavior of a cancer-killing virus that fits tumor cells perfectly and leaves healthy cells intact. Cancer is a chronic disease that kills millions of people worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is likely to be responsible for more …

View Post

Weight-loss drug could fight resistant lung cancer

In In The News by Barbara Jacoby

Posted by National University of Singapore From: futurity.org New research could pave the way for using versions of an existing drug to keep lung cancer cells from becoming drug-resistant. Researchers have discovered that a key enzyme in lipid metabolism controls the response to a class of targeted drugs called tyrosine kinase inhibitors (TKIs) in lung cancer. Cells use nutrients such …

View Post

Lung cancer risk drops substantially within five years of quitting, new research finds

In In The News by Barbara Jacoby

Source: Vanderbilt University Medical Center From: sciencenewsdaily.com Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer. That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.i These are the main findings of a new analysis of the landmark …

View Post

Lung cancer destroyed with tea leaf nanoparticles

In In The News by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com A new study has shown that lung cancer cells can be destroyed using nanoparticles derived from tea leaves. These tiny particles, called “quantum dots,” are 400 times thinner than a human hair, and producing them from tea leaves is safe and non-toxic. More and more research has been focusing on the potential uses of nanoparticles for …

View Post

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

In In The News by Barbara Jacoby

From: healthline.com The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. When Edith Pelka was diagnosed with advanced non-small cell lung cancer last summer, the retired New York nurse, yoga instructor, and self-described “straight shooter” thought her life was over. “After the surgeon told me that my tumor …

View Post

Immunotherapy transforms lung cancer, the biggest cancer killer

In In The News by Barbara Jacoby

By: Maggie Fox From: nbcnews.com Immune therapy drugs can transform lung cancer treatment, giving patients years of extra life, doctors reported Monday. They found that pre-treating lung cancer patients with immune therapy drugs before they have surgery can help melt away the tumor and at the same time limit or even stop its spread. And combinations of immunotherapy drugs have helped …

View Post

New drug attacks cancer-causing genes

In In The News by Barbara Jacoby

By: Tim Newman From: medicalnewstoday.com Two recent papers attack two cancer-related problems using the same drug. They hope that it might improve survival in breast and lung cancer and halt obesity-related cancers. Researchers from Michigan State University in East Lansing are using novel molecular routes to attack cancer. The scientists were particularly interested in bromodomain inhibitors (BET inhibitors). These are …

View Post

Promising drug may stop cancer-causing gene in its tracks

In In The News by Barbara Jacoby

Source: Michigan State University From: sciencedaily.com Michigan State University scientists are testing a promising drug that may stop a gene associated with obesity from triggering breast and lung cancer, as well as prevent these cancers from growing. These findings are based on two studies featured in the latest issue of Cancer Prevention Research. The first was a preclinical study, led …